Cell surface receptors regulate multiple and overlapping sets of intracellular signaling proteins. These effector molecules can be structurally organized into distinct signaling cascades, which act in concert to coordinate precise cellular responses following receptor engagement (1, 2). Immediate early reactions include reorganization of the actin cytoskeleton associated with changes in cell morphology and migration (3-5). Late reactions such as proliferation and differentiation require altered gene transcription (6 -8). To limit cellular responses and to prevent neoplastic transformation, activated receptors also initiate inhibitory feedback loops in an autonomous manner (9).In most cases, cell surface receptors do not couple directly to distinct signal chains. Instead they employ receptor-proximal adaptor proteins, which are devoid of enzymatic activity but become inducibly modified by phosphorylation (1, 10). This enables them to act as a transducer platform to collect and integrate incoming signals. As a consequence, intracellular signal transduction is not linear, i.e. one receptor-specific adaptor can simultaneously control different positive as well as negative signaling cascades. The molecular basis for the pleiotropic yet specific processing of signals is still poorly understood.The multimeric antigen receptors on B and T lymphocytes utilize adaptors called SLP 1 (Src homology (SH) 2 domaincontaining leukocyte proteins) (11). B cells express the 65 kDa family member SLP-65 (12), (also named BLNK (13) or BASH (14)) encompassing an N-terminal basic effector domain, various tyrosine phosphorylation sites, several consensus binding motifs for SH3 domains, and a C-terminal SH2 domain. Biochemical and genetic studies have established the mandatory role of SLP-65 for antigen-induced B cell activation and the subsequent initiation of immune effector functions (15). Moreover, the antigen-independent generation of B cells in the bone marrow also requires SLP-65 expression. In the absence of SLP-65, B cell development is severely compromised in mouse and man (16 -19). The dual role of SLP-65 for the development and activation of B cells demonstrates a remarkable plasticity of the BCR signaling machinery (20). The underlying molecular details, which allow BCR signal modulation in a differentiation stage-specific manner, are unknown.A key event for the activation of peripheral B cells is the BCR-induced tyrosine phosphorylation of SLP-65. This enables SLP-65 to nucleate the formation of a multiprotein complex by recruiting several SH2 domain-containing effector From the ‡Institute of Cellular and Molecular Immunology, Georg